Pipeline

OncoFAP – Radio Conjugate

Preclinic

Phase I

Phase II

Phase III

Various Solid Tumors (Imaging)

–

–

–

–

Various Solid Tumors (Therapy)

–

–

–

–

OncoFAP – Drug Conjugate

Preclinic

Phase I

Phase II

Phase III

Various Solid Tumors (Therapy)

–

–

–

–

Onco IX (PHC – 102, Imaging)

Preclinic

Phase I

Phase II

Phase III

Renal Cell Carcinoma (Imaging)

–

–

–

–

OncoFAP – Immunomodulator 

Preclinic

Phase I

Phase II

Phase III

Various Solid Tumors (Therapy)

–

–

–

–

OncoPSMA – Drug Conjugate

Preclinic

Phase I

Phase II

Phase III

Prostate Cancer (Therapy)

–

–

–

–

OncoFAP- Radio Conjugate

Various Solid Tumors (Imaging)

Preclinic

Phase I

Phase II

Phase III

Various Solid Tumors (Therapy)

Preclinic

Phase I

Phase II

Phase III

OncoFAP-Drug Conjugate

Various Solid Tumors (Therapy)

Preclinic

Phase I

Phase II

Phase III

Onco IX

Renal Cell Carcinoma (Imaging)

Preclinic

Phase I

Phase II

Phase III

OncoFAP-Immunomodulator

Various Solid Tumors (Therapy)

Preclinic

Phase I

Phase II

Phase III

OncoPSMA-Drug Conjugate

Prostate Cancer (Therapy)

Preclinic

Phase I

Phase II

Phase III

Philochem builds the chemical pipeline of the Philogen group. For the complete pipeline of the Philogen group see vedi www.philogen.com